Erasca, Inc. Investor Alert: Contact SBS by August 10, 2026 for Opportunity to Lead Securities Fraud Lawsuit
Schall Brown & Schwartz LLP issued a shareholder solicitation regarding a class action lawsuit against Erasca, Inc. concerning alleged violations of federal securities laws. The complaint alleges that Erasca made false and misleading statements regarding preclinical data for drug candidate ERAS-0015, specifically involving improper comparisons to Revolution Medicines.
Key figures
- Class period end
- April 26, 2026
- Class period start
- January 14, 2025
- Lead plaintiff deadline
- August 10, 2026
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.